Evidence map›Paper›PMID 36633292›Full record

ArticleJournal of psychopharmacology (Oxford, England)2023

Off the RADAR; questions regarding the trial protocol of a randomised controlled trial of antipsychotic reduction and discontinuation.

Sameer Jauhar, Paolo Fusar-Poli, David Foreman

Abstract readClinical Trial Protocol
In one paragraph

Article in Journal of psychopharmacology (Oxford, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sameer JauharDepartment of Psychological Medicine, IoPPN, King's College, London, UK.ORCID 0000-0002-3878-3659
Paolo Fusar-PoliDepartment of Psyhcosis Studies, IoPPN, King's College, London, UK.
David ForemanDepartment Child and Adolescent Psychiatry, King's College, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The randomised controlled trial of antipsychotic reduction and discontinuation addresses essential questions with regard to continued use of antipsychotics in schizophrenia, pertaining to social functioning and continued antipsychotic use. However, significant methodological issues stated in the trial protocol have the potential to confound interpretation of any findings. These include use of a non-blinded outcome measure, treatment as usual comparator and possible sample size issues.

Indexed as

Antipsychotic AgentsSchizophreniaHumansRandomized Controlled Trials as TopicSample SizeSocial InteractionAntipsychotic AgentsAntipsychoticsrandomised controlled trialschizophrenia

Identifiers

PMID36633292
PMCPMC10101177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.